Part 17 - [Reserved]  


§ 17.600 - Purpose.
§ 17.605 - Definitions.
§ 17.610 - Coverage.
§ 17.615 - Grounds for suspension of payments, suspension or termination of grants, or suspension or debarment.
§ 17.620 - Effect of violation.
§ 17.625 - Exception provision.
§ 17.630 - Certification requirements and procedures.
§ 17.635 - Reporting of and employee sanctions for convictions of criminal drug offenses.
Subpart A - General
§ 17.100 - Purpose.
§ 17.105 - Definitions.
§ 17.110 - Coverage.
§ 17.115 - Policy.
Subpart B - Effect of Action
§ 17.200 - Debarment or suspension.
§ 17.205 - Ineligible persons.
§ 17.210 - Voluntary exclusion.
§ 17.215 - Exception provision.
§ 17.220 - Continuation of covered transactions.
§ 17.225 - Failure to adhere to restrictions.
Subpart C - Debarment
§ 17.300 - General.
§ 17.305 - Causes for debarment.
§ 17.310 - Procedures.
§ 17.311 - Investigation and referral.
§ 17.312 - Notice of proposed debarment.
§ 17.313 - Opportunity to contest proposed debarment.
§ 17.314 - Debarring official's decision.
§ 17.315 - Settlement and voluntary exclusion.
§ 17.320 - Period of debarment.
§ 17.325 - Scope of debarment.
Subpart D - Suspension
§ 17.400 - General.
§ 17.405 - Causes for suspension.
§ 17.410 - Procedures.
§ 17.411 - Notice of suspension.
§ 17.412 - Opportunity to contest suspension.
§ 17.413 - Suspending official's decision.
§ 17.415 - Period of suspension.
§ 17.420 - Scope of suspension.
Subpart E - Responsibilities of GSA, Agency and Participants
§ 17.500 - GSA responsibilities.
§ 17.505 - FEMA responsibilities.
§ 17.510 - Participants' responsibilities.
Subpart F - Drug-Free Workplace Requirements (Grants)
Appendix A to Part 17 - Certification Regarding Debarment, Suspension, and Other Responsibility Matters - Primary Covered Transactions
Appendix B to Part 17 - Certification Regarding Debarment, Suspension, Ineligibility and Voluntary Exclusion - Lower Tier Covered Transactions
Appendix C to Part 17 - Certification Regarding Drug-Free Workplace Requirements
Appendix to Part 17 - Certification Regarding Drug-Free Workplace Requirements